Search Results 51-60 of 14932 for Tamoxifen
The purpose of this study is to compare the effectiveness of fulvestrant to anastrozole or tamoxifen in treating invasive lobular breast cancer, by measuring ...
... tamoxifen; Developing a new drug to replace tamoxifen for people with low CYP2D6 enzyme activity; Developing a new drug for women with resistance to aromatase ...
... tamoxifen and raloxifene, a Mayo Clinic-led study has found. Mayo Clinic oncologist, James Ingle, M.D., says, “Our findings are important, because we ...
... tamoxifen. Developing a new medicine to replace tamoxifen for people with low CYP2D6 enzyme activity. Developing a new medicine for breast cancer that is ...
... tamoxifen, for the treatment of estrogen receptor alpha-positive (ERα+) ... Using laboratory models, we demonstrated that endoxifen is primarily responsible for ...
Encorafenib is also used in combination with cetuximab to treat cancer of the colon and rectum that has spread and has the BRAF V600E mutations after previous ...
Blocking estrogen helps stop cancer from forming. Hormone-blocking medicines that are used to lower breast cancer risk include: Tamoxifen; Raloxifene (Evista) ...
Lapatinib is also used together with letrozole to treat postmenopausal women with hormone-receptor positive and HER2-receptor positive metastatic breast cancer.
It is also used for women who have already had other cancer treatments (eg, tamoxifen). Female hormones that occur naturally in the body can increase the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.